Starting from these clinical findings, a fewyears later, another research group studied these effects of the drug and reported an increaseof SMN mRNA and protein level in fibroblast cells derived from SMA patients[53]. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.